These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 26963004)
1. Epidemiologic, Clinicopathologic, Diagnostic, and Management Challenges of Pityriasis Rubra Pilaris: A Case Series of 100 Patients. Ross NA; Chung HJ; Li Q; Andrews JP; Keller MS; Uitto J JAMA Dermatol; 2016 Jun; 152(6):670-5. PubMed ID: 26963004 [TBL] [Abstract][Full Text] [Related]
2. Pityriasis rubra pilaris: clinicopathological study of 32 cases from Lebanon. Marrouche N; Kurban M; Kibbi AG; Abbas O Int J Dermatol; 2014 Apr; 53(4):434-9. PubMed ID: 24783259 [TBL] [Abstract][Full Text] [Related]
3. [How I treat...pityriasis rubra pilaris]. Fraiture AL; Braham C; Piérard-Franchimont C; Piérard GE Rev Med Liege; 2002 Jun; 57(6):363-5. PubMed ID: 12180027 [TBL] [Abstract][Full Text] [Related]
4. Pityriasis Rubra Pilaris in a 3-Year-Old Male. Stacey SK; Novek SJ; Maddox CL Mil Med; 2016 Mar; 181(3):e298-301. PubMed ID: 26926758 [TBL] [Abstract][Full Text] [Related]
5. Methotrexate treatment in a case of juvenile pityriasis rubra pilaris. Boyd AH; Polcari IC Pediatr Dermatol; 2018 Jan; 35(1):e62-e63. PubMed ID: 29044698 [TBL] [Abstract][Full Text] [Related]
6. Refractory pityriasis rubra pilaris treated with etanercept, adalimumab, or ustekinumab: A retrospective investigation. Maloney NJ; Hisaw LD; Worswick S Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 29034547 [TBL] [Abstract][Full Text] [Related]
7. Pityriasis rubra pilaris: evolution of challenges in promising treatment options. Sehgal VN; Srivastava G; Verma P Skinmed; 2012; 10(1):18-23. PubMed ID: 22324172 [TBL] [Abstract][Full Text] [Related]
8. A Review on Pityriasis Rubra Pilaris. Wang D; Chong VC; Chong WS; Oon HH Am J Clin Dermatol; 2018 Jun; 19(3):377-390. PubMed ID: 29302927 [TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis in a patient with pityriasis rubra pilaris. Frikha F; Frigui M; Masmoudi H; Turki H; Bahloul Z Pan Afr Med J; 2010 Aug; 6():6. PubMed ID: 21436949 [TBL] [Abstract][Full Text] [Related]
10. Treatment of pityriasis rubra pilaris type I: a systematic review. Engelmann C; Elsner P; Miguel D Eur J Dermatol; 2019 Oct; 29(5):524-537. PubMed ID: 31789274 [TBL] [Abstract][Full Text] [Related]
11. Pityriasis rubra pilaris--a retrospective single center analysis over eight years. Gemmeke A; Schönlebe J; Koch A; Wollina U J Dtsch Dermatol Ges; 2010 Jun; 8(6):439-44. PubMed ID: 20202046 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of Ixekizumab Treatment for Patients With Pityriasis Rubra Pilaris: A Single-Arm Trial. Haynes D; Strunck JL; Topham CA; Ortega-Loayza AG; Kent G; Cassidy PB; Hu R; Choate K; Wang Z; Liu Y; Greiling TM JAMA Dermatol; 2020 Jun; 156(6):668-675. PubMed ID: 32293641 [TBL] [Abstract][Full Text] [Related]
15. Successful treatment of pityriasis rubra pilaris (type 1) under combination of infliximab and methotrexate. Barth D; Harth W; Treudler R; Simon JC J Dtsch Dermatol Ges; 2009 Dec; 7(12):1071-4. PubMed ID: 19689446 [TBL] [Abstract][Full Text] [Related]
16. Pityriasis rubra pilaris as an initial presentation of hepatocellular carcinoma. Sharma S; Weiss GR; Paulger B Dermatology; 1997; 194(2):166-7. PubMed ID: 9094467 [TBL] [Abstract][Full Text] [Related]
17. Acantholytic pityriasis rubra pilaris associated with topical use of imiquimod 5%: case report and literature review. Leite OG; Tagliolatto S; Souza EM; Cintra ML An Bras Dermatol; 2020; 95(1):63-66. PubMed ID: 31789270 [TBL] [Abstract][Full Text] [Related]